Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-021-00550-x http://scihub22266oqcxt.onion/10.1038/s41577-021-00550-x 33927374!8082486!33927374     free     free     free Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Immunol 2021 ; 21 (6): 395-404 Nephropedia Template TP {{tp|p=33927374|t=2021. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection |pdf=|usr=}}{{33927374}} gab.com Text Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33927374 #FOAvip Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is central to long-term control of the current pandemic. Despite our rapidly advancing knowledge of immune memory to SARS-CoV-2, understanding how these responses translate into protection against reinfection at both the individual and population levels remains a major challenge. An ideal outcome following infection or after vaccination would be a highly protective and durable immunity that allows for the establishment of high levels of population immunity. However, current studies suggest a decay of neutralizing antibody responses in convalescent patients, and documented cases of SARS-CoV-2 reinfection are increasing. Understanding the dynamics of memory responses to SARS-CoV-2 and the mechanisms of immune control are crucial for the rational design and deployment of vaccines and for understanding the possible future trajectories of the pandemic. Here, we summarize our current understanding of immune responses to and immune control of SARS-CoV-2 and the implications for prevention of reinfection. Twit Text FOAVip Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33927374 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33927374 #FOAvip English Wikipedia <ref>{{Cite pmid|33927374}}</ref> Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection #MMPMID33927374 Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP Nat Rev Immunol 2021[Jun]; 21 (6): 395-404 PMID33927374show ga Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is central to long-term control of the current pandemic. Despite our rapidly advancing knowledge of immune memory to SARS-CoV-2, understanding how these responses translate into protection against reinfection at both the individual and population levels remains a major challenge. An ideal outcome following infection or after vaccination would be a highly protective and durable immunity that allows for the establishment of high levels of population immunity. However, current studies suggest a decay of neutralizing antibody responses in convalescent patients, and documented cases of SARS-CoV-2 reinfection are increasing. Understanding the dynamics of memory responses to SARS-CoV-2 and the mechanisms of immune control are crucial for the rational design and deployment of vaccines and for understanding the possible future trajectories of the pandemic. Here, we summarize our current understanding of immune responses to and immune control of SARS-CoV-2 and the implications for prevention of reinfection. |*SARS-CoV-2/genetics/immunology[MESH] |Antibodies, Neutralizing/blood[MESH] |Antibodies, Viral/blood[MESH] |Antigenic Variation[MESH] |B-Lymphocytes/immunology[MESH] |CD4-Positive T-Lymphocytes/immunology[MESH] |CD8-Positive T-Lymphocytes/immunology[MESH] |COVID-19 Vaccines/immunology/pharmacology[MESH] |COVID-19/*immunology/*prevention & control/virology[MESH] |Humans[MESH] |Immunologic Memory[MESH] |Models, Immunological[MESH] |Pandemics/*prevention & control[MESH] |Reinfection/*immunology/*prevention & control[MESH]Prospects for durable immune control of SARS-CoV-2 and prevention of r(epmc).pdf DeepDyve Pubget Overpricing